NCT04241146 is a NA clinical trial of Enteric Tube in Enteral Feeding Intolerance, sponsored by The University of Texas Health Science Center at San Antonio.

Who is sponsoring NCT04241146?

NCT04241146 is sponsored by The University of Texas Health Science Center at San Antonio.

What drugs are being tested in NCT04241146?

Interventions in NCT04241146: Enteric Tube, CORTRAK enteral access system.

What condition does NCT04241146 study?

NCT04241146 studies Enteral Feeding Intolerance.

Is NCT04241146 still recruiting?

NCT04241146 is currently completed. Last updated 25 February 2020.

Are results published for NCT04241146?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2020-02-25 · How we verify

NCT04241146

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optimal Feeding Tube Placement

Completed NA Results posted Last updated 25 February 2020

What this trial tests

NA trial testing Enteric Tube in Enteral Feeding Intolerance in 52 participants. Completed in 21 November 2019.

Timeline

6 January 2018

Primary endpoint
10 October 2018

21 November 2019

Quick facts

Lead sponsor	The University of Texas Health Science Center at San Antonio
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	52
Start date	6 January 2018
Primary completion	10 October 2018
Estimated completion	21 November 2019
Sites	1 location across United States

Drugs / interventions tested

Enteric Tube
CORTRAK enteral access system

Conditions studied

Enteral Feeding Intolerance — all drugs for Enteral Feeding Intolerance →

Sponsor

The University of Texas Health Science Center at San Antonio

Who can join

Under 18, any sex, with Enteral Feeding Intolerance. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Duration of Time Primary · Baseline to End of procedure up to 30 minutes

Time taken for placement of enteral tube

Group	Value	95% CI
Standard Blind Technique of Tube Placement	19	9.25 – 27.0
CORTRAK Enteral Access System (CEAS) Placement	2.5	2.0 – 7.5

Number of X-Rays Secondary · Baseline to End of procedure up to 30 minutes

Number of X-rays required to achieve correct tube placement

Group	Value	95% CI
Standard Blind Technique of Tube Placement	2	1 – 4
CORTRAK Enteral Access System (CEAS) Placement	1	1 – 1

Sponsor's own description

A randomized controlled trial comparing current standard blind method to CORTRAK enteral access system (CEAS), an FDA approved electromagnetic device to place enteric tubes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Enteral Feeding Intolerance

Currently open trials in the same condition.

NCT07312890 — Bedside Observation by Clinical Ultrasound for Stomach Expansion · NA · recruiting
NCT07092423 — Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury. · NA · recruiting

Other The University of Texas Health Science Center at San Antonio trials

Trials by the same sponsor.

NCT07280897 — SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial · NA · not yet recruiting
NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07056699 — SGLT2i, Pioglitazone, and Ketone Production in T1D · Phase 3 · not yet recruiting
NCT06609343 — Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis · Phase 1, PHASE2 · not yet recruiting
NCT07437053 — Sarcopenia in Chronic Kidney Disease (CKD) Patients · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04241146 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center at San Antonio
Last refreshed: 25 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04241146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing